近年来，动脉粥样硬化指数（atherogenic indices），像血浆致动脉粥样硬化指数（atherogenic index of plasma，AIP）、Castelli 风险指数（Castelli’s risk indexes，CRI - I 和 CRI - II）、致动脉粥样硬化系数（atherogenic coefficient，AC）等，成为评估心血管疾病（CVD）风险的重要工具。

在心血管疾病的众多风险因素中，脂质紊乱占据重要地位，像血浆致动脉粥样硬化指数（Atherogenic Index of Plasma，AIP）、Castelli 风险指数 I 和 II（Castelli Risk Index I & II，CRI - I & II）、致动脉粥样硬化系数（Atherogenic Coefficient，AC）等传统指标，能从脂质层面反映患病 ...

Investigators examined inclisiran’s effects beyond LDL-C and showed that it also reduces atherogenic lipoproteins in a profound and sustained manner. Atherogenic lipoproteins – non-HDL-C ...

A cardioprotective dietary pattern is recommended to reduce atherogenic cholesterol and other ASCVD risk factors, such as hypertension. Components of a cardioprotective dietary pattern that reduce ...

Please confirm that you would like to log out of Medscape. If you log out, you will be required to enter your username and password the next time you visit. Log out ...

Small, dense HDL possesses potent antioxidative activity but this is compromised under conditions of atherogenic dyslipidemia. HDL functional deficiency frequently coincides with reductions in HDL ...

Please provide your email address to receive an email when new articles are posted on . Utilizing commercially available assays, researchers demonstrated the feasibility of evaluating the ...

These, the study's authors said, "suggest a shift towards a more anti-atherogenic" overall profile of blood lipid parameters. They noted, too, that other markers of cardiovascular risk including ...

1 Non-HDL-C represents total cholesterol minus cholesterol from HDL particles; apo B represents the total number of atherogenic particles, since 1 apo B molecule is found on each LDL, very low–density ...